ABCL Stock Analysis Overview
What this means: InvestorsObserver gives AbCellera Biologics Inc. (ABCL) an overall rank of 32, which is below average. AbCellera Biologics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 32 means that 68% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ABCL Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
ABCL Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
ABCL Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
ABCL Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
ABCL Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
ABCL Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
ABCL Stock Analysis Overview
What this means: InvestorsObserver gives AbCellera Biologics Inc. (ABCL) an overall rank of 32, which is below average. AbCellera Biologics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 32 means that 68% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.